Authors
Loading...
Pre-clinical evaluation shows Lactobacillus paracasei KBL382 reduces pro-inflammatory cytokines in IBD, indicating therapeutic potential.
Gwang Pyo Ko (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: